Revenue To Dramatically Increase As Colorado M.E.D. Officially Approved Transfer Of Management Control Of Denver Testing Lab Yesterday Monday February 22, 2016 To Pazoo, Inc. Licensee Harris Lee Colorado, LLC

Feb 23, 2016, 08:00 ET from Pazoo, Inc.

WHIPPANY, N.J., Feb. 23, 2016 /PRNewswire/ -- Pazoo, Inc. (OTC Pinks: PZOO) (German WKN#: A1J3DK), is extremely pleased to announce that the Colorado Medical Enforcement Division (MED) officially approved the transfer of the lab management from the owner Front Range Analytics, LLC to Pazoo licensee Harris Lee Colorado, LLC as of Monday, February 22, 2016. This change of management will result in several important fundamental developments.

First, Pazoo, through its wholly owned subsidiary Harris Lee, LLC, will immediately transition from a small consulting fee to earning money off of every single test conducted, dramatically increasing revenue generated. Secondly, through all of the aggressive marketing efforts over the last few months, numerous growers, edible producers, CBD and THC oil companies and hemp producers have committed to test with the Harris Lee Colorado lab management team now that the transfer of management control is complete, immediately leading to additional revenues.

As previously released 12/4/15, this Colorado lab was approved for residual solvents testing (RSA) back in December.  Being certified for the RSA will open up the market for potential clients, including extraction labs and manufacturers, and will allow the lab to regain former clients who left last year because this crucial certification was not in place.  Furthermore, this Colorado lab can now accept industrial hemp samples. By accepting industrial hemp samples, Harris Lee Colorado will be able to dramatically diversify the clientele and greatly increase sample intake resulting in an exponential increase in revenue generation. Harris Lee Colorado is positioning to be the premier testing lab in the state of Colorado.

Click here to see the official MED approval document:

Pazoo CEO David Cunic stated, "This truly is the watershed moment that we have been working towards. We have now officially transitioned from an early stage company to an aggressive growth stage company where we are not only have immediately seen a dramatic daily increase in revenue, but expect to experience exponential accelerated growth rates for the foreseeable future.  These growth rates should further accelerate well into and through the end of 2016 with the Las Vegas Lab coming on line in the very near future. We thank the investment community for sticking by Pazoo leading up to this moment."

About Pazoo, Inc.:

Pazoo, Inc. is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly owned subsidiaries, Harris Lee and MA & Associates, Pazoo provides industry leading laboratory testing of cannabis. Pazoo is licensed to test cannabis in Nevada, with a focus on expansion into other states. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website, and features industry experts from both the health and wellness arena and the pet industry. Lastly, our newly formed wholly owned subsidiary CK Distribution LLC, provides the marketing and sales agent for the distribution of non-controlled hemp products throughout the USA. Non-controlled hemp products are the items utilized by the industry that support grow facilities, infusion companies and dispensaries.

Safe Harbor Statement:

This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.

SOURCE Pazoo, Inc.